(Q35904830)

11 August 2017

1 reference

title

Antiepileptic drugs in the treatment of anxiety disorders: role in therapy (English)

1 reference

11 August 2017

author name string

Michael Van Ameringen

1

1 reference

11 August 2017

Catherine Mancini

2

1 reference

11 August 2017

Beth Pipe

3

1 reference

11 August 2017

Mark Bennett

4

1 reference

11 August 2017

language of work or name

1 reference

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

64

1 reference

11 August 2017

issue

19

1 reference

11 August 2017

page(s)

2199-2220

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464190-00004

11 August 2017

exact match

0 references

cites work

Neurobiological mechanisms of social anxiety disorder

1 reference

12 December 2020

An open trial of topiramate in the treatment of generalized social phobia.

1 reference

12 December 2020

Pharmacotherapy of generalized anxiety disorder

1 reference

12 December 2020

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

1 reference

12 December 2020

Pregabalin in generalized anxiety disorder: a placebo-controlled trial

1 reference

12 December 2020

Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder

1 reference

12 December 2020

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

12 December 2020

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder

1 reference

12 December 2020

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

1 reference

12 December 2020

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

12 December 2020

Placebo-controlled trial of moclobemide in social phobia

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

1 reference

12 December 2020

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

1 reference

12 December 2020

Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy

1 reference

12 December 2020

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study

1 reference

12 December 2020

Valproate therapy for chronic, combat-induced posttraumatic stress disorder

1 reference

12 December 2020

Inhibition of the Amygdala: Key to Pathological States?

1 reference

12 December 2020

Valproic acid for panic disorder associated with multiple sclerosis

1 reference

12 December 2020

Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder

1 reference

12 December 2020

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

12 December 2020

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

12 December 2020

Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

12 December 2020

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

1 reference

12 December 2020

Valproate pretreatment for the difficult-to-treat patient with OCD

1 reference

12 December 2020

Panic disorder: treatment with valproate

1 reference

12 December 2020

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

1 reference

12 December 2020

Carbamazepine for PTSD

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

Gabapentin as a potential treatment for anxiety disorders.

1 reference

12 December 2020

Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder

1 reference

12 December 2020

Topiramate titration and tolerability

1 reference

12 December 2020

Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy

1 reference

12 December 2020

A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam

1 reference

12 December 2020

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

12 December 2020

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

12 December 2020

Oxcarbazepine treatment of posttraumatic stress disorder

1 reference

12 December 2020

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

1 reference

12 December 2020

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

12 December 2020

Vigabatrin and posttraumatic stress disorder

1 reference

12 December 2020

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

12 December 2020

Divalproex in posttraumatic stress disorder

1 reference

12 December 2020

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

12 December 2020

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

12 December 2020

Rebound psychiatric and physical symptoms after gabapentin discontinuation

1 reference

12 December 2020

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

1 reference

12 December 2020

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial

1 reference

12 December 2020

Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder

1 reference

12 December 2020

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

12 December 2020

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

12 December 2020

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

1 reference

12 December 2020

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial

1 reference

12 December 2020

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

12 December 2020

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

12 December 2020

Carbamazepine, alprazolam withdrawal, and panic disorder.

1 reference

12 December 2020

Valproate treatment of panic disorder and lactate-induced panic attacks.

1 reference

12 December 2020

Gabapentin treatment for posttraumatic stress disorder

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

12 December 2020

Valproate treatment of comorbid panic disorder and affective disorders in two alcoholic patients

1 reference

12 December 2020

A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population

1 reference

12 December 2020

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial

1 reference

12 December 2020

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

12 December 2020

Treatment of Panic Disorder and Benzodiazepine Withdrawal With Valproate

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with tiagabine

1 reference

12 December 2020

Valproic acid for the treatment of social anxiety disorder

1 reference

12 December 2020

Tolerance to fluoxetine

1 reference

12 December 2020

The effect of citalopram in panic disorder

1 reference

12 December 2020

Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.

1 reference

12 December 2020

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder

1 reference

12 December 2020

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

12 December 2020

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

12 December 2020

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

12 December 2020

Placebo-controlled study of gabapentin treatment of panic disorder

1 reference

12 December 2020

Carbamazepine versus lithium in mania: a double-blind study

1 reference

12 December 2020

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

12 December 2020

Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.

1 reference

12 December 2020

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

12 December 2020

Valproate in the treatment of acute mania. A placebo-controlled study

1 reference

12 December 2020

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder

1 reference

12 December 2020

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

12 December 2020

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

12 December 2020

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

The EEG in obsessive-compulsive disorder.

1 reference

12 December 2020

The role of GABA in anxiety disorders

1 reference

12 December 2020

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

1 reference

12 December 2020

Carbamazepine in panic disorder.

1 reference

12 December 2020

Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study

1 reference

12 December 2020

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

12 December 2020

Fluoxetine in posttraumatic stress disorder

1 reference

12 December 2020

Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities

1 reference

12 December 2020

Tiagabine improves panic and agoraphobia in panic disorder patients

1 reference

12 December 2020

Lack of efficacy of carbamazepine in the treatment of panic disorder.

1 reference

12 December 2020

Treatment of panic disorder and comorbid substance abuse with divalproex sodium

1 reference

12 December 2020

Valproic acid and panic disorder

1 reference

12 December 2020

Valproate monotherapy in an SRI-intolerant OCD patient.

1 reference

12 December 2020

Carbamazepine in obsessive-compulsive disorder.

1 reference

12 December 2020

Valproate in combat-related posttraumatic stress disorder.

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.

1 reference

12 December 2020

Sodium valproate and clonazepam for treatment-resistant panic disorder

1 reference

12 December 2020

10.2165/00003495-200464190-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1020617272

0 references

1 reference